Data / Form D filings / Bryn Pharma, Inc.
Bryn Pharma, Inc.: Form D filings
Bryn Pharma, Inc., a health care company in Lebanon, NJ, filed 10 Form D notices with the SEC between 2018 and 2025. The latest, on August 14, 2025, reports $4.7 million sold of a $4.7 million offering to 105 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 26 STILL HOLLOW RD, Lebanon, NJ, 08833
- Phone
- (412) 401-1129
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1746919
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | New notice | $4,692,830 | $4,692,830 | 105 | Apr 10, 2025 | sec.gov | |
| Jul 5, 2023 | Amendment | $30,000,000 | $26,724,100 | $3,275,900 | 105 | Apr 25, 2023 | sec.gov |
| May 10, 2023 | New notice | $20,000,000 | $15,000,000 | $5,000,000 | 82 | Apr 25, 2023 | sec.gov |
| Oct 11, 2022 | Amendment | $50,000,000 | $43,510,775 | $6,489,225 | 246 | Jul 6, 2021 | sec.gov |
| Dec 17, 2021 | Amendment | $30,000,000 | $28,279,798 | $1,720,202 | 169 | Jul 6, 2021 | sec.gov |
| Jul 20, 2021 | New notice | $15,000,000 | $5,150,000 | $9,850,000 | 16 | Jul 6, 2021 | sec.gov |
| Jun 22, 2020 | Amendment | $35,000,000 | $26,000,000 | $9,000,000 | 127 | Oct 18, 2019 | sec.gov |
| Nov 4, 2019 | New notice | $15,000,000 | $15,000,000 | 106 | Oct 18, 2019 | sec.gov | |
| Feb 21, 2019 | New notice | $18,000,000 | $17,223,780 | $776,220 | 77 | Feb 8, 2019 | sec.gov |
| Jul 30, 2018 | New notice | $15,000,000 | $9,251,965 | $5,748,035 | 72 | Jul 16, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anne Whitaker | Director | |
| Michael Kaseta | Director | |
| Jeff Hartness | Director | |
| Steven Hartman | Director | |
| Joshua Ziel | Executive Officer | |
| Michelle Lobel | Director | |
| Steven Killmeyer | Executive Officer | |
| Marc Rapaport | Director | |
| Lisa Licht | Director | |
| Sandra Loreaux | Director | |
| James Borneman | Executive Officer | |
| Kate Soper Diaz | Director |
Other health care companies in New Jersey that filed recently
- SURGICAL CENTER OF SOUTH JERSEY LP $280,125 · Oct 8, 2026
- Morris County Surgical Center, LLC $140,380 · Sep 28, 2026
- Acuitive Technologies, Inc. $1.9 million · Sep 24, 2026
- Meca Industries Corp $37,500 · Sep 21, 2026
- ZT Technology PE 1, LLC offering · Sep 9, 2026
- OLI Technologies, Inc. offering · Sep 4, 2026
Every Form D from the week of Aug 11, 2025 · All recent filings in New Jersey · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Bryn Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.